Recovery trial results show that Regeneron’s intra-trial antibody combination therapy reduces the risk of death in hospitalized patients with severe COVID-19 seronegative. Results from a randomized...
Drug majors Roche India and Cipla announced the launch of Roche’s antibody cocktails in India on May 24th. This is priced at Rs 59,750 per dose...
Recent Comments